• Latest Posts

AstraZeneca adds to its treatments for blood cancer with $100M deal

Sponsored by 10 Mar 2022

Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?

Gene-Edited T Cell Therapy Players Battle Safety Doubts

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial


Genmab and Janssen Suffer Combination Therapy Setback

“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“

Startup Scout 2 Mar 2018

This Spanish Biotech Is Developing Stem-Cell Targeted Leukemia Treatments

Novartis Takes Genmab’s Leukemia Drug Off the Market